Tag: endoAVF

“We know which DCB to use”—but many other questions remain in...

A first-time presentation at the 2024 Charing Cross (CX) International Symposium (23–25 April, London, UK) of five-year data from the IN.PACT AV Access study...
haemodialysis

Pathfinder Medical and Imperial College London awarded Innovate UK Smart grant...

Pathfinder Medical has been awarded a Smart grant for a £1.1 million (US$1.4 million) project by Innovate UK, the UK's innovation agency. A press...
top 10

Vascular News’ top 10 most popular stories of June 2022

Coverage of this year's Leipzig Interventional Course (LINC; 6–9 June, Leipzig, Germany) and Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM; 15–18 June,...
endoAVF

Vascular access creation: EndoAVF keeps future options open, but is not...

Based on over four years of experience in a single centre, Robert Shahverdyan (Asklepios Klinik Barmbek, Hamburg, Germany) claims that endovascular arteriovenous fistula (endoAVF)...

Dialysis tech firm Pathfinder Medical secures £8.5 million

Pathfinder Medical, which has developed a proprietary technology to guide and accurately align catheters in endovascular procedures allowing clinicians to make connections across blood...

Ellipsys™ Vascular Access System provides consistently great outcomes for AV fistula...

 Alexandros Mallios (Paris, France) and Robert Shahverdyan (Hamburg, Germany) talk to Vascular News about some of the benefits of the Ellipsys™ Vascular Access System...
ellipsys five-year data

Benefits of percutaneous fistula creation further bolstered by five-year Ellipsys data

The Ellipsys vascular access system (Avenu Medical/Medtronic) can be used to easily and safely create durable percutaneous arteriovenous fistulas (pAVFs) for haemodialysis—with new, long-term...
fist assist fa-1 device

Fist Assist device achieves significant perforator vein dilation for improved endoAVF...

Fist Assist Devices has announced that data associated with the p-FACT cohort, a subset of the recently completed, non-significant risk Fist Assist clinical trial...
Avenu Ellipsys

Study finds Ellipsys system allows kidney patients to begin dialysis sooner...

The Ellipsys vascular access system (Avenu Medical) reduces the time before patients with kidney failure can start lifesaving dialysis treatments, while requiring fewer secondary...

UK-first innovation could save lives of dialysis patients

Barts Health NHS Trust has performed a UK-first operation outside of trial setting that could reduce mortality and risks of infection in patients with...

CX 2020 LIVE: Vascular Access session showcases new technologies, while debate...

The CX 2020 LIVE Vascular Access Consensus session sparked global interest, with chair Nick Inston (Birmingham, UK) and moderator Domenico Valenti (London, UK) taking...

BD receives FDA 510(k) clearance of WavelinQ 4F endoAVF system

BD has announced the 510(k) clearance from the US Food and Drug Administration (FDA) for the WavelinQ 4F endoAVF system earlier this month. The endoAVF...
endoAVF

Meta-analysis shows positive experience for endoAVF patients for haemodialysis access

An international meta-analysis of clinical experience in patients who received an endovascular arteriovenous fistula (endoAVF) for haemodialysis access was presented at Leipzig Interventional Course...